Bridge To Life — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Bridge to Life is a commercial-stage, private company and a recognized leader in the organ preservation and perfusion market. Its core offerings include the established Belzer UW® static cold storage solutions and the innovative VitaSmart™ HOPE system, which has recently gained FDA clearance and seen its first commercial use in the U.S. The company is strategically positioned to address the critical shortage of viable donor organs by extending preservation times and improving organ quality, thereby aiming to increase transplant success rates and save more lives.

Organ Transplantation

Technology Platform

Hypothermic Oxygenated Perfusion (HOPE) and static cold storage solutions for organ preservation.

Opportunities

The massive global organ shortage creates a urgent need for technologies that can increase the utilization of marginal donor organs.

Bridge to Life's HOPE system addresses this by potentially resuscitating and preserving organs that would otherwise be discarded.

Expansion of HOPE technology to other solid organs (e.g., kidney, heart, lung) represents a significant long-term growth opportunity.

Risk Factors

Intense competition from companies developing alternative (especially normothermic) perfusion technologies poses a risk of technological displacement.

Successful market adoption requires demonstrating clear cost-effectiveness and navigating complex hospital procurement and reimbursement processes, which can be slow and challenging.

Competitive Landscape

Bridge to Life competes in the organ preservation market with companies offering static cold storage solutions (e.g., XVIVO, Paragonix) and machine perfusion systems. Key competitors in perfusion include TransMedics (normothermic OCS® system), OrganOx (normothermic liver perfusion), and XVIVO with its hypothermic and normothermic platforms. Bridge to Life differentiates with a focused HOPE approach, cost-effectiveness, and the established brand of its Belzer UW® solutions.

More companies in Digital Health & Biotech SaaS →More companies in United States →